Healthcare Stocks

PM Truss urged to put billions into social care

 PM Truss urged to put billions into social care

In her campaign, the PM had pledged to spend £13 billion on social care.

Read More...
More sales, more profits, but less dividends: Emma Walmsley’s roadmap for New GSK

More sales, more profits, but less dividends: Emma Walmsley’s roadmap for New GSK

GlaxoSmithKline’s (LON:GSK) CEO Emma Walmsley has said that by 2031, the company plans to make sales of over £33 billion and increase adjusted operating profit by 10 per cent in the next half-decade. However, the company plans to slash ...

Read More...
EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

The European Union has approved the drug Koselugo, manufactured by AstraZeneca (LON: AZN) and Merck & Co, to treat children above 3 years of age with neurofibromatosis type 1 (NF1), a rare genetic disease. The drug was approved as per the SPRIN...

Read More...
What are the recent business updates unveiled by MyHealthChecked?

What are the recent business updates unveiled by MyHealthChecked?

Summary MHC had generated revenue of £26,146 from the launch of the COVID-19 PCR nasal swab test kit in December 2020. The Company had reported a net loss of negative £3.76 million for FY20. MHC had a cash balance of £465,671...

Read More...
Astrazeneca's Tagrisso Drug Gets Nod for Lung Cancer Treatment

Astrazeneca's Tagrisso Drug Gets Nod for Lung Cancer Treatment

Summary Tagrisso has been approved by the European Commission (EC) to treat patients with early-stage epidermal growth factor receptor-mutated non-small cell lung cancer. The EC approval came about due to positive results from the ADAURA phase ...

Read More...
GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

Summary GSK, Sanofi launched the final phase III trials of their delayed Covid vaccine. The phase III trial for the vaccine have 35,000 people enrolled, who are 18 years and above from different countries. The trial would study the efficiency ...

Read More...
Vectura Group agrees to £958 million takeover deal by Carlyle Group

Vectura Group agrees to £958 million takeover deal by Carlyle Group

Vectura Group PLC (LON: VEC) is the healthcare stock listed on the London stock exchange. VEC’s shares have generated a return of 77.83% in the last 12 months. VEC is listed on the FTSE 250 index. On 27 May 2021, the Company will hold its An...

Read More...
Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyle takeover

Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyle takeover

Summary Vectura Group shares rallied very sharply on Wednesday, 26 May, hitting a 4-year high The drugmaker has agreed on the terms of acquisition with Carlyle Group Bidco will be acquiring all the share capital of Vectura for a cash considera...

Read More...
After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine Research Centre

After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine Research Centre

Summary The UK has been ranked as world’s top developed country with the best healthcare system overall. Innova, the world’s largest rapid Covid-19 test maker, recently decided to start manufacturing in the UK. Pfizer, one of the w...

Read More...
Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

Summary A recent GlobalData survey highlighted a majority of US, and UK healthcare professionals believed the UK is an attractive destination for research and manufacturing in the sector post Brexit. Vaccine maker AstraZeneca’s share drop...

Read More...
Vaccination Visibly Helps in Abating Existential Threat to Life

Vaccination Visibly Helps in Abating Existential Threat to Life

Sumamry As per PHE, the Covid-19 inoculation programme alone has helped in preventing more than 11,000 deaths in England Various medical experts initially believed that there could be severe issues with the people who have received the Covid-19...

Read More...